Blog

Drug Assistance program and patient responsibilities on drugs

Author: P. Kavya

Drug Assistance Program

If you don’t have insurance or have inadequate insurance and cannot afford your medication, several pharmaceutical firms, governmental agencies, and nonprofit organisations provide drug assistance programmes (PAPs) that supply free or low-cost medications.Benefits of various programmes can differ. Depending on your insurance and medication, you can be qualified for assistance to lower their copay for medications. If you satisfy specific requirements or don’t have adequate health insurance to cover your medications, you might be eligible for free medications.

One of the most reliable ways to lower health care costs is to implement patient cost sharing in the form of copayments, coinsurance, and deductibles. Imposing cost sharing, however, decreases the demand for medical treatment, which puts insurers’ interests at odds with those of drug and device manufacturers, healthcare providers, and other service providers, who typically profit when customers utilise more services.

Programs for patients’ support, such as medication management and counselling, may enhance the quality of care for people with complicated chronic disease states.

When a patient has numerous comorbid diseases, financial and other socioeconomic pressures (such as education level) can make it difficult for them to take their medications as directed, which can cause more difficulties. When patients were asked why their diseases weren’t under control in one study, the main response was that they couldn’t afford their drugs because of hefty co-pays and other medication-related expenses. Another typical explanation is that people were ashamed to ask more questions of a doctor since they did not fully comprehend the diagnosis or course of therapy. The adoption of successful treatments may also be hampered by cultural differences and attitudes.

Objectives – The aim of this paper is to examine the influence of patient assistance programmes and technology on medication adherence and to identify impediments to medication adherencePrograms for patients’ support, such as counselling and medication management, may enhance treatment for those with chronic diseases requiring complicated therapies. More frequently, in practise, technology is being used as a tool to encourage adherence.

Method – A literature search of peer-reviewed systematic reviews, experimental, quasi-experimental, and observational reports written in English and published within the last fifteen years was carried out in the secondary databases PubMed/MEDLINE and EBSCOhost. The terms patient aid programme, pharmacist function, technology, adherence or compliance, income, and health were all searched. To perform this review, researchers adhered to the PRESS criteria. To collect data, they used the PRISMA approach (Preferred Reporting Items for Systematic Reviews and Meta-Analyses).

By reading the titles and abstracts of each article, the lead investigator first chose those that had the suggested keywords. Following an initial examination, two co-investigators looked more into the chosen papers. With the help of two additional co-investigators, any discrepancies or misunderstandings were resolved through analysis until the required consent was obtained. Data were extracted from the included studies using a standardised, pre-piloted form, and the following categories were included: the role of pharmacists in patient assistance programmes, the number of patients, factors that affect medication adherence, income, and the use of technology in adherence and limitations.

Discussion-

• According to our research, there are numerous obstacles to drug adherence. Increased hospitalizations, admissions/readmissions, and healthcare expenses are unfortunate effects of pharmaceutical non-adherence.
• The majority of non-adherence predictors are changeable. For instance, involving patients in treatment decisions and counseling can help patients feel more in control of their clinical conditions and remove any uncertainty and doubts they may have about their regimens.
• It can also educate patients about the risks of polypharmacy and the potential for additional health problems if non-adherence occurs. When pharmacists are included on the healthcare team to help with these efforts, medication adherence has been shown to improve, according to several studies.
• By educating patients and streamlining prescription regimens through services like medication therapy management, pharmacists help improve medication adherence.
• The National Governors Association Center for Best Practices reported that “the incorporation of pharmacists into chronic care is suggested by the crucial role that drug management plays in treating chronic diseases.”Teams could lead to better health outcomes.
• Patient assistance programs aid people in paying for their drugs, but they may potentially be improved to help more people get over other obstacles to adherence. Integrating technology can encourage patient adherence to their drugs, resulting in the management of chronic illnesses, a reduction in clinical consequences and hospitalizations, and a reduction in healthcare costs.

The influence of medication assistance programs-

• Pharmacy costs are reduced when patients are successfully enrolled in manufacturers’ drug assistance programs.
• Medication assistance programs give prescriptions to patients who cannot afford to buy them and have no other way to obtain them, therefore it stands to reason that these initiatives would increase compliance, reduce unfavorable events, and cut costs.
• Free outpatient care, free inpatient stays, and free prescription medication reduced hospital expenses overall and decreased the number of inpatient and outpatient visits.

PATIENT RESPONSIBILITIES ON DRUGS

Abstract-

Typically, any obvious issues brought on by pharmaceutical errors will be picked up on first by the patients and those who are caring for them. They generally won’t be able to tell the difference between pharmaceutical mistakes, negative drug reactions, or “side effects.”

Patients, however, do not always disclose all of the issues they believe they have and are more inclined to reveal those they believe to be serious. If patients are worried about how their doctors may react, they may not report difficulties that can be attributable to their prescriptions. When patients express concerns, doctors may react inappropriately, such as by disregarding them. To get patients to report possible drug side effects, several authors have suggested using a symptom checklist.

The problem for the specialist is to decide how much data to present and the appropriate method of doing so given that many patients request information on side effects of medications.

The challenge for the patient-

In many circumstances, patients and their partners or carers will be the first to detect any observable issue brought on by a pharmaceutical error. Adverse outcomes can occasionally be sudden or well-known. The patient might not be aware that the issue is related to the drug they are taking because other outcomes could be delayed or unanticipated.

• Assessment
• Interpretation
• Recognition of any medication-related issues is a challenge for patients

According to studies, some people test their own prescription medications to determine whether they are effective and how they affect their daily lives. These assessments involve balancing the benefits and costs of drugs and reacting to any side effects that may be felt. People’s initial assessments of drug-related adverse effects may be confirmed or refuted by these tests; if the attribution is believed to have been supported, the patient may decide to cease taking the medicine.

Duties of the patient-

1. Motive:

Whenever a new medication is prescribed, be aware of the condition it is meant to address. Patients will benefit from reviewing this to ensure proper medication administration. This is crucial for medicines used to treat symptoms like headache, nausea, or diarrhea as soon as they appear.

2. Impact and Negative Effects:

Go over the medication’s intended effects as well as any potential or anticipated negative effects. Patients can use this to check whether a drug is functioning properly. Additionally, it will assist patients in recognizing unfavorable side effects that could need treatment.

3. Name and characteristics:

Talk about the characteristics of the medication, such as the kind (such as tablet or liquid), color, size, consistency, and shape. Ask the picture of the drug if it is possible.

Patients who take a few extra steps may be able to tell if their pharmacy filled the prescription incorrectly. Patients should be urged to double-check refills for typos. Patients should be urged to communicate with their pharmacist if anything regarding a filled prescription seems different from what you reviewed.

5. Cautions:

Ensure that you are aware of the contraindications to using a drug. This may include using a vehicle after drinking. Understand the necessity of the warnings when examining the medication’s label. You may say, “Do not consume alcohol and drive when taking this prescription as the medication can cause your vision to blur and make you drowsy,” as opposed to simply, “Do not consume alcohol  and drive while taking this medication.”

6.Ask questions:

Understand how important it is to speak up, ask questions, and voice concerns. Make an effort to feel more at ease when conversing with a clinician.

8. Transparency Is Important:

• The doctor needs as much information as possible regarding a patient’s medical history, including any prescription drugs and nutritional supplements the individual is currently taking or may have previously taken.
• It is crucial for patients to communicate with the doctor in this process. The impact of this information on clinicians’ treatment decisions, such as new prescriptions or modifications to a pharmaceutical regimen, may not be fully appreciated or understood by patients.
• Recognize the role that patients play and the need of a thorough, accurate medication record. In the event that you forgot to take a medication, inform the doctor right away.

9. Recognizing and Addressing Side Effects:

Any drug may have unwanted effects. Patients should be aware of the negative effects that are frequently linked to their drug, as was previously mentioned. Additionally, kids ought to be aware of what they should do and what not to do if they encounter any negative effects, such as quitting a drug or taking additional medications. Inform patients of what to do if a side effect occurs and they are unclear of how to react, including how to contact you or another doctor who can offer advice, or heading to the urgent care.

Conclusion-

One of the biggest issues facing medicine is patient noncompliance with pharmaceutical therapy. A significant contributor to noncompliance is a patient’s inability to pay for their drugs, which can result in quality of life decline, early death, job loss, an increase in adverse effects that need hospitalizations and other outcomes, and untimely death. Given this, the rising cost of prescription pharmaceuticals, and the fact that many people only have limited access to prescription insurance, medication assistance programs are a crucial resource that can give eligible patients access to prescriptions for little to no cost or even free. But if medical professionals aren’t aware of these programs’ existence or don’t know how to sign up, their ability to enrol patients may be restricted.

For patients to distinguish between an error, a side effect, the drug’s typical remedial action, and the signs of their underlying ailment, they need information to assist them make the right attributions. Even though it’s true that some patients don’t want information, research reveals that people desire more information than they do concerning side effects and that clinicians frequently underestimate the amount upon which patients want this knowledge. Doctors addressed patient complaints about medications in a variety of ways, including altering the medication, offering information, assuring patients that the advantages outweighed the risks, stating that there were no other options, or warning them that adverse reactions were to be expected.

Despite the fact that certain patients may have it difficult to understand information concerning the possibility of negative side effects, experts may find it challenging and may conclude that some patients lack the cognitive ability to do so. The difficulty for specialists is determining how much information a specific patient genuinely needs and is able to absorb, as is the case with the sharing of all knowledge about hazards. You can start by asking the patient how many they want to understand and what they they previously know. Generally speaking, conversation should be a multiple conversations where experts and patients can share knowledge and viewpoints regarding those dangers. Professionals must assist patients by supplying pertinent information in understandable, frequently graphic formats.

References

1. Gellad WF, Huskamp HA, Li A, Zhang Y, Safran DG, Donohue JM. Use of prescription drug samples and patient assistance programs, and the role of doctor–patient communication. J. [PMC free article][PubMed] [Google Scholar]
2. Kletas V, Lemos MD. Development of a systematic approach to pharmaceutical industry’s patient assistance programs on accessing unfunded cancer drugs. J Oncol Pharm Pract. 2018;24:18–21. [PubMed] [Google Scholar]
3. Schommer JC, Doucette WR, Planas LG. Establishing pathways for access to pharmacist-provided patient care. J Am Pharm Assoc (2003) 2015;55:664–8. [PubMed] [Google Scholar]